It might be suggested that CD44 expression could be used as a marker for the prediction of gastric cancer development, especially in patients with premalignant gastric lesions carrying AG or GG, who was selected to surveillance follow-up for gastric cancer prevention. The gene discussed is CD44; the disease is gastric cancer.